284 related articles for article (PubMed ID: 36044865)
1. Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection.
SoRelle ED; Dai J; Reinoso-Vizcaino NM; Barry AP; Chan C; Luftig MA
Cell Rep; 2022 Aug; 40(9):111286. PubMed ID: 36044865
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes
SoRelle ED; Reinoso-Vizcaino NM; Horn GQ; Luftig MA
Front Immunol; 2022; 13():1001145. PubMed ID: 36248899
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci.
SoRelle ED; Reinoso-Vizcaino NM; Dai J; Barry AP; Chan C; Luftig MA
Cell Rep; 2023 Aug; 42(8):112958. PubMed ID: 37561629
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.
Mrozek-Gorska P; Buschle A; Pich D; Schwarzmayr T; Fechtner R; Scialdone A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16046-16055. PubMed ID: 31341086
[TBL] [Abstract][Full Text] [Related]
5. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
6. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.
Hatton OL; Harris-Arnold A; Schaffert S; Krams SM; Martinez OM
Immunol Res; 2014 May; 58(2-3):268-76. PubMed ID: 24619311
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.
Price AM; Luftig MA
Adv Virus Res; 2014; 88():279-313. PubMed ID: 24373315
[TBL] [Abstract][Full Text] [Related]
8. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
12. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
[TBL] [Abstract][Full Text] [Related]
13. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.
Koganti S; Clark C; Zhi J; Li X; Chen EI; Chakrabortty S; Hill ER; Bhaduri-McIntosh S
J Virol; 2015 May; 89(9):5002-11. PubMed ID: 25717101
[TBL] [Abstract][Full Text] [Related]
14. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
15. Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification.
Li CW; Jheng BR; Chen BS
PLoS One; 2018; 13(8):e0202537. PubMed ID: 30133498
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA-seq reveals transcriptomic heterogeneity mediated by host-pathogen dynamics in lymphoblastoid cell lines.
SoRelle ED; Dai J; Bonglack EN; Heckenberg EM; Zhou JY; Giamberardino SN; Bailey JA; Gregory SG; Chan C; Luftig MA
Elife; 2021 Jan; 10():. PubMed ID: 33501914
[TBL] [Abstract][Full Text] [Related]
17. Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus.
Megyola C; Ye J; Bhaduri-McIntosh S
Virol J; 2011 Feb; 8():84. PubMed ID: 21352549
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
